haloperidol has been researched along with n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daugé, V; Feger, J; Maldonado, R; Roques, BP | 1 |
| Cheĭdo, MA; Idova, GV | 1 |
2 other study(ies) available for haloperidol and n,n-diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine
| Article | Year |
|---|---|
Chronic blockade of D2 but not D1 dopamine receptors facilitates behavioural responses to endogenous enkephalins, protected by kelatorphan, administered in the accumbens in rats.
Topics: Animals; Behavior, Animal; Benzazepines; Dipeptides; Dose-Response Relationship, Drug; Enkephalin, Leucine; Enkephalins; Haloperidol; Injections; Male; Motor Activity; Narcotic Antagonists; Nucleus Accumbens; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Opioid; Receptors, Opioid, delta; Sulpiride | 1990 |
[The participation of the delta opioid receptors in immunomodulation].
Topics: Animals; Cyproheptadine; Enkephalin, Leucine; Haloperidol; Immunization; Male; Mice; Mice, Inbred CBA; Narcotic Antagonists; Neuroimmunomodulation; Pituitary Gland; Receptors, Opioid, delta; Thymus Gland | 1993 |